Cataract and drugs of ingredients of sofosbuvir (a real world drug study)
Summary:
Cataract is found among people who take drugs with ingredients of sofosbuvir, especially for people who are male, 50-59 old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 21,826 people who have side effects when taking drugs with ingredients of sofosbuvir from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Sofosbuvir, Sovaldi.
21,826 people reported to have side effects when taking drugs with ingredients of sofosbuvir.
Among them, 12 people (0.05%) have Cataract
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 1,891 drugs and 2,131 conditions by eHealthMe. Check the latest studies of Cataract.
Number of reports submitted per year:

Time on drugs with ingredients of sofosbuvir when people have Cataract *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Cataract when taking drugs with ingredients of sofosbuvir *:
- female: 33.33 %
- male: 66.67 %
Age of people who have Cataract when taking drugs with ingredients of sofosbuvir *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 54.55 %
- 60+: 45.45 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Hepatitis C: 7 people, 58.33%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Daklinza: 5 people, 41.67%
- Olysio: 1 person, 8.33%
- Harvoni: 1 person, 8.33%
Other side effects people have besides Cataract *:
You may use this to check any potential undetected side effects.
- Vision Blurred: 6 people, 50.00%
- Visual Impairment: 3 people, 25.00%
- Retinal Disorder (disease of retina): 2 people, 16.67%
- Lens Dislocation: 2 people, 16.67%
- Eye Disorder: 2 people, 16.67%
- Vitreous Floaters (spots before the eyes): 1 person, 8.33%
- Rashes (redness): 1 person, 8.33%
- Muscle Aches (muscle pain): 1 person, 8.33%
- Memory Loss: 1 person, 8.33%
- Macular Hole (small break in the macula, the central area of the retina): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Related studies
Drugs with ingredients of sofosbuvir, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on sofosbuvir. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Novolog and Blood Pressure Increased for Women aged 40-49 - 10 seconds ago
- Novolog and Htn for Women aged 40-49 - 11 seconds ago
- Novolog and Hypertension for Women aged 40-49 - 11 seconds ago
- Novolog and Hbp for Women aged 40-49 - 11 seconds ago
- Novolog and Blood Pressure - High for Women aged 40-49 - 12 seconds ago
- Novolog and High Blood Pressure for Women aged 40-49 - 12 seconds ago
- Could Methylphenidate Hydrochloride cause Restless Leg Syndrome? - 24 seconds ago
- Could Irinotecan Hydrochloride cause Cheilitis? - 24 seconds ago
- Actos and Sleep Disorder for Men aged 40-49 - 29 seconds ago
- Actos and Excessive Sleepiness for Men aged 40-49 - 29 seconds ago